Friday, December 18, 2020

SEC Charges Biotech Company and CEO With Fraud Concerning COVID-19 Blood Testing Device

The Securities and Exchange Commission today announced charges against California-based biotechnology company Decision Diagnostics Corp. and its CEO, Keith Berman, with making false and misleading claims in numerous press releases that the company had…

Read the Full Press Release
Have a securities law question? Call Sallah Astarita & Cox at 212-509-6544.

No comments: